ImClone Systems Incorporated
(NASDAQ:IMCL)|
69.99 0.00 (0.00%) Jan 06 - Close |
|
|
|
- Compare IMCL with:
- View: Line | Candlestick
Company Profile
ImClone Systems Incorporated
180 Varick Street
New York, NY 10014
United States - Map
Phone: (212) 645-1405
Fax: (212) 645-2054
Website: www.imclone.com
State of incorporation: Delaware
CEO: John H. Johnson
Employees: 997
Sector: Healthcare
Industry Group: Drugs
Industry: Biotechnology
Res/dev biopharmaceutical products
A biopharmaceutical Company, engaged in the development and commercialization of a portfolio of targeted treatments for the medical needs of patients with cancer.
Recent news for IMCL
-
A Bloody Good Deal for Johnson & Johnson
Motley Fool - Nov 24 2008 at 3:38 ET
-
Fitch's downgrades Eli Lilly over ImClone debt
AP - Nov 24 2008 at 3:30 ET
-
Eli Lilly completes ImClone buyout
AP - Nov 24 2008 at 2:23 ET
-
Fitch cuts Eli Lilly to 'A+' on ImClone acquisition
MarketWatch - Nov 24 2008 at 2:17 ET
-
Cancer network funded by Bristol-Myers, ImClone
bizjournals.com - Nov 24 2008 at 1:05 ET
-
MarketWatch - Nov 24 2008 at 9:41 ET
-
Motley Fool - Nov 21 2008 at 4:15 ET
-
Curtain Falls on ImClone Drama, as Lilly Completes Tender
The Wall Street Journal Online - Nov 21 2008 at 1:12 ET
-
Moody's cuts Eli Lilly on ImClone acquisition
MarketWatch - Nov 21 2008 at 10:15 ET
-
Eli Lilly buys majority of ImClone in tender offer
AP - Nov 21 2008 at 9:59 ET
